FDA Panel: Pancreatic Islet Transplant Should Be Option for T1D

(MedPage Today) -- An FDA advisory committee agreed that cadaveric allogeneic pancreatic islet cells (donislecel) for treating brittle type 1 diabetes is worth the risks for certain patients.
In a 12-4 vote Thursday with one abstention, members...